Abstract
A transthyretin (TTR) mutation is described in a 44 year old French woman from Caen who presented at the age of 40 with neuropathy in all four extremities, diarrhoea, and orthostatic hypotension. Her father died with a similar syndrome including vitreous opacities. A nerve biopsy from the proband showed amyloid deposits which stained with anti-transthyretin. Direct genomic DNA sequencing of TTR exon 3 showed both thymine and cytosine in the position corresponding to the second base of codon 71. This codes for a variant alanine (GCG) as well as the normal valine (GTG), indicating that the proband is heterozygous for the substitution. Since this substitution does not result in the creation or abolition of a restriction endonuclease recognition site, a new technique (PCR-IMRA) was used to create an RFLP. Using a 24 bp nucleotide mutagenesis primer in the PCR reaction, a new NspBII site is created on amplification of the variant allele. With this method a 170 bp TTR exon 3 PCR product was generated for both the normal and the variant allele. On digestion of the PCR product with NspBII, DNA from a heterozygous subject showed both the 170 bp undigested product from the normal allele and a 146 bp digestion product from the variant allele. By PCR-IMRA, two of five children of the proband were positive for the variant allele. This non-radioactive technique gives a rapid method for testing subjects at risk for this mutation.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Benson M. D., Dwulet F. E. Prealbumin and retinol binding protein serum concentrations in the Indiana type hereditary amyloidosis. Arthritis Rheum. 1983 Dec;26(12):1493–1498. doi: 10.1002/art.1780261211. [DOI] [PubMed] [Google Scholar]
- Fitch N. J., Akbari M. T., Ramsden D. B. An inherited non-amyloidogenic transthyretin variant, [Ser6]-TTR, with increased thyroxine-binding affinity, characterized by DNA sequencing. J Endocrinol. 1991 May;129(2):309–313. doi: 10.1677/joe.0.1290309. [DOI] [PubMed] [Google Scholar]
- Gautreau C., Rahuel C., Cartron J. P., Lucotte G. Comparison of two methods of high-molecular-weight DNA isolation from human leucocytes. Anal Biochem. 1983 Oct 15;134(2):320–324. doi: 10.1016/0003-2697(83)90304-4. [DOI] [PubMed] [Google Scholar]
- Harrison H. H., Gordon E. D., Nichols W. C., Benson M. D. Biochemical and clinical characterization of prealbuminCHICAGO: an apparently benign variant of serum prealbumin (transthyretin) discovered with high-resolution two-dimensional electrophoresis. Am J Med Genet. 1991 Jun 15;39(4):442–452. doi: 10.1002/ajmg.1320390415. [DOI] [PubMed] [Google Scholar]
- Nichols W. C., Liepnieks J. J., McKusick V. A., Benson M. D. Direct sequencing of the gene for Maryland/German familial amyloidotic polyneuropathy type II and genotyping by allele-specific enzymatic amplification. Genomics. 1989 Oct;5(3):535–540. doi: 10.1016/0888-7543(89)90020-7. [DOI] [PubMed] [Google Scholar]
- Sakaki Y., Yoshioka K., Tanahashi H., Furuya H., Sasaki H. Human transthyretin (prealbumin) gene and molecular genetics of familial amyloidotic polyneuropathy. Mol Biol Med. 1989 Apr;6(2):161–168. [PubMed] [Google Scholar]
- Satier F., Nichols W. C., Benson M. D. Diagnosis of familial amyloidotic polyneuropathy in France. Clin Genet. 1990 Dec;38(6):469–473. doi: 10.1111/j.1399-0004.1990.tb03615.x. [DOI] [PubMed] [Google Scholar]